Far less than it was two weeks ago with several hundred million on offer at .1c
Far less than last week with nearly 200m on offer at .2
The company is making strides and they are getting their story out. Look at the media engagements and write-ups they're getting online which have been referenced here.
It's a spec stock with enormous potential. No one is comparing this to FMG, but at .2 it's less than $6m MC. I won't bother listing their virtues over again as they are repeated almost as much as Assailed's ramblings in this and other threads.
8 million gone today. 10 million yesterday. Plenty more in the last few weeks.
It's a spec stock. If it wasn't fragile, it wouldn't be a spec stock. This is the wrong end of the market for stability, but where the potential lies.
For all I know it could be a total duster, obviously. But at < $6m MC, in my opinion it's absolutely worth a position in to see if they can drill PEP-11, and to see where their medical tech IPO and the new MM venture take the company. When I started posting it was trading at .1 which was $3m MC. Now the .2s are falling and there were a lot more of them just last week.
DYOR of course. I don't mind taking a risk for potential bags but if fragile stocks aren't for you, there's about 2500 others on the ASX.
All IMO
Add to My Watchlist
What is My Watchlist?
